Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat ca...
Q1 2026
May 7, 2026
FY 2025
Mar 12, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 7, 2025